These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10590268)

  • 1. T(h)1 but not T(h)0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides.
    Lópex-Días de Cerio AL; Casares N; Lasarte JJ; Sarobe P; Pérez-Mediavilla LA; Ruiz M; Prieto J; Borrás-Cuesta F
    Int Immunol; 1999 Dec; 11(12):2025-34. PubMed ID: 10590268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo induction of cytotoxic T cell response by a free synthetic peptide requires CD4+ T cell help.
    Fayolle C; Deriaud E; Leclerc C
    J Immunol; 1991 Dec; 147(12):4069-73. PubMed ID: 1684372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. Evidence that two peptide residues are buried in the MHC molecule.
    Romero P; Eberl G; Casanova JL; Cordey AS; Widmann C; Luescher IF; Corradin G; Maryanski JL
    J Immunol; 1992 Mar; 148(6):1871-8. PubMed ID: 1541825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines.
    Shirai M; Chen M; Arichi T; Masaki T; Nishioka M; Newman M; Nakazawa T; Feinstone SM; Berzofsky JA
    J Infect Dis; 1996 Jan; 173(1):24-31. PubMed ID: 8537666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.
    Porgador A; Staats HF; Faiola B; Gilboa E; Palker TJ
    J Immunol; 1997 Jan; 158(2):834-41. PubMed ID: 8993001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides.
    Franke ED; Corradin G; Hoffman SL
    J Immunol; 1997 Oct; 159(7):3424-33. PubMed ID: 9317141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of helper T cell-inducing peptides from conserved regions in HIV-1 env in a noncovalent mixture with a CTL-inducing V3-loop peptide for in vivo induction of long-lasting systemic CTL response.
    Nehete PN; Arlinghaus RB; Sastry KJ
    Viral Immunol; 1994; 7(4):189-97. PubMed ID: 7576033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of a cytotoxic T cell response by co-injection of a T helper peptide and a cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): further enhancement by pre-injection of IFA alone.
    Valmori D; Romero JF; Men Y; Maryanski JL; Romero P; Corradin G
    Eur J Immunol; 1994 Jun; 24(6):1458-62. PubMed ID: 7515816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T-cells specific for natural IgE peptides downregulate IgE production.
    Chen SS; Gong J; Yang YM; Oettgen H; Zanetti M
    Cell Immunol; 2005 Jan; 233(1):11-22. PubMed ID: 15913585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL.
    Kuhröber A; Schirmbeck R; Reimann J
    Eur J Immunol; 1994 May; 24(5):1172-80. PubMed ID: 7514132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
    Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
    J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct.
    Lasarte JJ; Sarobe P; Gullón A; Prieto J; Borrás-Cuesta F
    Cell Immunol; 1992 Apr; 141(1):211-8. PubMed ID: 1532538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.
    Carbone FR; Moore MW; Sheil JM; Bevan MJ
    J Exp Med; 1988 Jun; 167(6):1767-79. PubMed ID: 2455012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides.
    Hioe CE; Qiu H; Chend PD; Bian Z; Li ML; Li J; Singh M; Kuebler P; McGee P; O'Hagan D; Zamb T; Koff W; Allsopp C; Wang CY; Nixon DF
    Vaccine; 1996 Apr; 14(5):412-8. PubMed ID: 8735553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells.
    Takahashi H; Nakagawa Y; Yokomuro K; Berzofsky JA
    Int Immunol; 1993 Aug; 5(8):849-57. PubMed ID: 8398980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity.
    Casares N; Lasarte JJ; de Cerio AL; Sarobe P; Ruiz M; Melero I; Prieto J; Borrás-Cuesta F
    Eur J Immunol; 2001 Jun; 31(6):1780-9. PubMed ID: 11385623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization.
    Bristol JA; Orsini C; Lindinger P; Thalhamer J; Abrams SI
    Cell Immunol; 2000 Nov; 205(2):73-83. PubMed ID: 11104579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragment.
    Plotnicky-Gilquin H; Cyblat-Chanal D; Aubry JP; Champion T; Beck A; Nguyen T; Bonnefoy JY; Corvaïa N
    J Virol; 2002 Oct; 76(20):10203-10. PubMed ID: 12239295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.